These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Yu W; Liu C; Ye J; Zou W; Zhang N; Xu W Nanotechnology; 2009 May; 20(21):215102. PubMed ID: 19423923 [TBL] [Abstract][Full Text] [Related]
3. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Vighi E; Ruozi B; Montanari M; Battini R; Leo E Int J Pharm; 2010 Apr; 389(1-2):254-61. PubMed ID: 20100555 [TBL] [Abstract][Full Text] [Related]
4. Employment of cationic solid-lipid nanoparticles as RNA carriers. Montana G; Bondì ML; Carrotta R; Picone P; Craparo EF; San Biagio PL; Giammona G; Di Carlo M Bioconjug Chem; 2007; 18(2):302-8. PubMed ID: 17253655 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Huang ZR; Hua SC; Yang YL; Fang JY Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178 [TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636 [TBL] [Abstract][Full Text] [Related]
7. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Vighi E; Ruozi B; Montanari M; Battini R; Leo E Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876 [TBL] [Abstract][Full Text] [Related]
8. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method]. Yang Y; Feng JF; Zhang H; Luo JY Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822 [TBL] [Abstract][Full Text] [Related]
9. Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector. Vighi E; Montanari M; Hanuskova M; Iannuccelli V; Coppi G; Leo E Int J Pharm; 2013 Jan; 440(2):161-9. PubMed ID: 22982257 [TBL] [Abstract][Full Text] [Related]
10. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo]. Hu LD; Tang X; Cui FD Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775 [TBL] [Abstract][Full Text] [Related]
11. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969 [TBL] [Abstract][Full Text] [Related]
13. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells. Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199 [TBL] [Abstract][Full Text] [Related]
14. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Attama AA; Müller-Goymann CC Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of monodisperse biotinylated p(NIPAAm)-coated iron oxide magnetic nanoparticles and their bioconjugation to streptavidin. Narain R; Gonzales M; Hoffman AS; Stayton PS; Krishnan KM Langmuir; 2007 May; 23(11):6299-304. PubMed ID: 17451262 [TBL] [Abstract][Full Text] [Related]
16. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Schubert MA; Müller-Goymann CC Eur J Pharm Biopharm; 2005 Sep; 61(1-2):77-86. PubMed ID: 16011893 [TBL] [Abstract][Full Text] [Related]
17. Further studies on targeted DNA transfer to cells using a highly efficient delivery system of biotinylated transferrin and biotinylated polylysine complexed to streptavidin. Schoeman R; Joubert D; Ariatti M; Hawtrey AO J Drug Target; 1995; 2(6):509-16. PubMed ID: 7773613 [TBL] [Abstract][Full Text] [Related]
18. Biotinylated bionanocapsules for displaying diverse ligands toward cell-specific delivery. Shishido T; Azumi Y; Nakanishi T; Umetsu M; Tanaka T; Ogino C; Fukuda H; Kondo A J Biochem; 2009 Dec; 146(6):867-74. PubMed ID: 19710034 [TBL] [Abstract][Full Text] [Related]
19. Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery. Bondi ML; Azzolina A; Craparo EF; Lampiasi N; Capuano G; Giammona G; Cervello M J Drug Target; 2007 May; 15(4):295-301. PubMed ID: 17487698 [TBL] [Abstract][Full Text] [Related]
20. [Preparation of solid lipid nanoparticles by microemulsion technique]. Mao SR; Wang YZ; Ji HY; Bi DZ Yao Xue Xue Bao; 2003 Aug; 38(8):624-6. PubMed ID: 14628457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]